Cg Oncology Inc (NASDAQ: CGON) is -29.50% lower on its value in year-to-date trading and has touched a low of $14.80 and a high of $46.99 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CGON stock was last observed hovering at around $20.11 in the last trading session, with the day’s gains setting it 0.11%.
Currently trading at $20.22, the stock is -8.73% and -19.63% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.24 million and changing 0.55% at the moment leaves the stock -36.30% off its SMA200. CGON registered -46.28% loss for a year compared to 6-month loss of -46.11%. The firm has a 50-day simple moving average (SMA 50) of $25.1588 and a 200-day simple moving average (SMA200) of $31.7442.
The stock witnessed a -26.42% gain in the last 1 month and extending the period to 3 months gives it a -31.71%, and is 13.72% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.97% over the week and 9.60% over the month.
Cg Oncology Inc (CGON) has around 113 employees, a market worth around $1.54B and $1.14M in sales. Profit margin for the company is -7729.32%. Distance from 52-week low is 36.62% and -56.97% from its 52-week high. The company has generated returns on investments over the last 12 months (-12.00%).
The EPS is expected to shrink by -26.34% this year
208.0 institutions hold shares in Cg Oncology Inc (CGON), with institutional investors hold 104.84% of the company’s shares. The shares outstanding are 76.15M, and float is at 46.04M with Short Float at 17.48%. Institutions hold 98.38% of the Float.
The top institutional shareholder in the company is DECHENG CAPITAL LLC with over 5.46 million shares valued at $172.33 million. The investor’s holdings represent 8.1903 of the CGON Shares outstanding. As of 2024-06-30, the second largest holder is TCG CROSSOVER MANAGEMENT, LLC with 3.67 million shares valued at $115.87 million to account for 5.5067 of the shares outstanding. The other top investors are BRAIDWELL LP which holds 3.31 million shares representing 4.9655 and valued at over $104.48 million, while BVF INC/IL holds 3.6278 of the shares totaling 2.42 million with a market value of $76.33 million.
Cg Oncology Inc (CGON) Insider Activity
The most recent transaction is an insider sale by POST LEONARD E, the company’s Director. SEC filings show that POST LEONARD E sold 1,000 shares of the company’s common stock on Mar 17 ’25 at a price of $28.00 per share for a total of $28000.0. Following the sale, the insider now owns 0.0 shares.
Still, SEC filings show that on Feb 18 ’25, POST LEONARD E (Director) disposed off 1,000 shares at an average price of $28.61 for $28610.0. The insider now directly holds 0 shares of Cg Oncology Inc (CGON).
